Evotec SE (EVO:NASDAQ)
$3.375 -0.04 (-1.03%)
Analysed Evotec SE (EVO:NASDAQ) News Sources
Centauri Therapeutics extends Series A to £30m with investment from AMR Action Fund
Insider Media
Centauri Therapeutics extends Series A to £30 M with £6 M investment from AMR Action Fund to support progression of lead clinical candidate
News-Medical.Net on MSN
Centauri Therapeutics Extends Series A to GBP30M With GBP6M Investment From AMR Action Fund to Support Progression of Lead Clinical Candidate
MarketWatch
Global Drug Discovery Informatics Market to Surpass USD 11.18 Billion by 2035, Driven by AI-Powered Platforms, Genomic Breakthroughs, and Accelerating Global Drug Pipelines ...
Yahoo Finance
European Commission Authorizes Ranluspec Strengthening Sandoz Ophthalmology Portfolio and Biosimilar Strategy
EuropaWire
What is the current price of Evotec SE (EVO:NASDAQ)?
The current price of Evotec SE (EVO:NASDAQ) is $3.375.
Evotec SE (EVO:NASDAQ) absolute price change since previous trading day?
The absolute price change of Evotec SE (EVO:NASDAQ) since the previous trading day is $-0.04.
Evotec SE (EVO:NASDAQ) percentage price change since previous trading day?
The percentage price change of Evotec SE (EVO:NASDAQ) since the previous trading day is -1.03%.
What is This Week's average sentiment score for Evotec SE (EVO:NASDAQ)?
This Week's average sentiment score for Evotec SE (EVO:NASDAQ) is 83 out of 100.
What is This Week's average sentiment for Evotec SE (EVO:NASDAQ)?
This Week's sentiment for Evotec SE (EVO:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.